What is Proscia?
Proscia is a software company dedicated to accelerating the transformation of pathology into a data-driven discipline. Its flagship product, the Concentriq digital pathology platform, integrates seamlessly with powerful AI applications to unlock new insights for researchers and clinicians. By digitizing traditional workflows, Proscia enables laboratories to improve diagnostic accuracy and operational efficiency. The company occupies a critical position at the intersection of enterprise software and life sciences, providing the infrastructure necessary for the next generation of precision medicine. Its market position is bolstered by a commitment to solving complex, real-world problems in healthcare through scalable, AI-enabled technology.
How much funding has Proscia raised?
Proscia has raised a total of $129.6M across 7 funding rounds:
Angel/Seed
$1M
Private Equity
$927K
Series A
$8.3M
Debt
$350K
Series B
$23M
Series C
$46M
Other Financing Round
$50M
Angel/Seed (2016): $1M with participation from Robin Hood Ventures, TCP Venture Capital, Emerald Development Managers, and A-Level Capital
Private Equity (2017): $927K, investors not publicly disclosed
Series A (2018): $8.3M supported by Flybridge Capital Partners
Debt (2020): $350K featuring PPP
Series B (2020): $23M backed by Hitachi Ventures and BA Venture Partners
Series C (2024): $46M with participation from Scale Venture Partners, Triangle Peak Partners, Alpha Intelligence Capital, Hitachi Ventures, and Highline Capital Management
Other Financing Round (2025): $50M led by GPG Advisers, Triangle Peak Partners, Emerald Development Managers, Razor's Edge Management, Interwoven Ventures, Insight Partners, AI Capital Partners, and Fusion Fund
Key Investors in Proscia
GPG Advisers
GPG Advisers is an integrated professional services firm that specializes in the real estate and alternative investments industries, providing expertise to enhance portfolio value and asset performance.
Triangle Peak Partners
Triangle Peak Partners is a multi-strategy asset management firm specializing in growth stage investments in technology, clean tech, and energy sectors, aiming to drive value in innovative companies.
Emerald Development Managers
Emerald Development Managers is a venture capital firm that invests in exceptional scientific and engineering teams, focusing on sectors such as life sciences, enterprise software, and sustainability.
What's next for Proscia?
With the successful completion of this major strategic investment, Proscia is well-positioned to expand its footprint in the global digital pathology market. The company is expected to prioritize the further development of its AI-driven diagnostic applications and the scaling of its enterprise-level infrastructure. As the healthcare industry increasingly adopts digital solutions to address diagnostic backlogs and improve patient care, Proscia's focus will likely remain on deepening its technological moat and fostering strategic partnerships with global health systems. This capital provides the necessary runway to accelerate product innovation and solidify its status as a category-defining entity in the health-tech ecosystem.
See full Proscia company page
